世界の特殊注射用ジェネリック医薬品市場インサイト及び予測(~2026年)

【英語タイトル】Global Specialty Injectable Generics Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV04700)・商品コード:QYR20NV04700
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:94
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは特殊注射用ジェネリック医薬品の世界市場について調査・分析した資料です。種類別(タイプI、タイプII)の市場規模、用途別(腫瘍、心臓血管、中枢神経系、感染症、自己免疫疾患)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別特殊注射用ジェネリック医薬品の競争状況、市場シェア
・世界の特殊注射用ジェネリック医薬品市場:種類別市場規模 2015年-2020年(タイプI、タイプII)
・世界の特殊注射用ジェネリック医薬品市場:種類別市場規模予測 2021年-2026年(タイプI、タイプII)
・世界の特殊注射用ジェネリック医薬品市場:用途別市場規模 2015年-2020年(腫瘍、心臓血管、中枢神経系、感染症、自己免疫疾患)
・世界の特殊注射用ジェネリック医薬品市場:用途別市場規模予測 2021年-2026年(腫瘍、心臓血管、中枢神経系、感染症、自己免疫疾患)
・北米の特殊注射用ジェネリック医薬品市場分析:米国、カナダ
・ヨーロッパの特殊注射用ジェネリック医薬品市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの特殊注射用ジェネリック医薬品市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の特殊注射用ジェネリック医薬品市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの特殊注射用ジェネリック医薬品市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、Fresenius、Mylan N.V.、Teva Pharmaceutical、Hikma Pharmaceuticals、Novartis AG、Uman Pharma、Baxter、Par Pharmaceutical、Sagent Pharmaceuticals、Teligent
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Specialty Injectable Generics Market
The global Specialty Injectable Generics market size is projected to reach US$ 10240 million by 2026, from US$ 9378.7 million in 2020, at a CAGR of 8.4%% during 2021-2026.

Global Specialty Injectable Generics Scope and Market Size
Specialty Injectable Generics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Injectable Generics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Fresenius
Mylan N.V.
Teva Pharmaceutical
Hikma Pharmaceuticals
Novartis AG
Uman Pharma
Baxter
Par Pharmaceutical
Sagent Pharmaceuticals
Teligent

Market segment by Type, the product can be split into
Type I
Type II
Market segment by Application, split into
Oncology
Cardiovascular
Central Nervous System
Infectious Diseases
Autoimmune Disorders

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Specialty Injectable Generics Revenue
1.4 Market by Type
1.4.1 Global Specialty Injectable Generics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Specialty Injectable Generics Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Cardiovascular
1.5.4 Central Nervous System
1.5.5 Infectious Diseases
1.5.6 Autoimmune Disorders
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Specialty Injectable Generics Market Perspective (2015-2026)
2.2 Global Specialty Injectable Generics Growth Trends by Regions
2.2.1 Specialty Injectable Generics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Specialty Injectable Generics Historic Market Share by Regions (2015-2020)
2.2.3 Specialty Injectable Generics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Specialty Injectable Generics Market Growth Strategy
2.3.6 Primary Interviews with Key Specialty Injectable Generics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Specialty Injectable Generics Players by Market Size
3.1.1 Global Top Specialty Injectable Generics Players by Revenue (2015-2020)
3.1.2 Global Specialty Injectable Generics Revenue Market Share by Players (2015-2020)
3.1.3 Global Specialty Injectable Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Specialty Injectable Generics Market Concentration Ratio
3.2.1 Global Specialty Injectable Generics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Specialty Injectable Generics Revenue in 2019
3.3 Specialty Injectable Generics Key Players Head office and Area Served
3.4 Key Players Specialty Injectable Generics Product Solution and Service
3.5 Date of Enter into Specialty Injectable Generics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Specialty Injectable Generics Historic Market Size by Type (2015-2020)
4.2 Global Specialty Injectable Generics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Specialty Injectable Generics Market Size by Application (2015-2020)
5.2 Global Specialty Injectable Generics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Specialty Injectable Generics Market Size (2015-2020)
6.2 Specialty Injectable Generics Key Players in North America (2019-2020)
6.3 North America Specialty Injectable Generics Market Size by Type (2015-2020)
6.4 North America Specialty Injectable Generics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Specialty Injectable Generics Market Size (2015-2020)
7.2 Specialty Injectable Generics Key Players in Europe (2019-2020)
7.3 Europe Specialty Injectable Generics Market Size by Type (2015-2020)
7.4 Europe Specialty Injectable Generics Market Size by Application (2015-2020)

8 China
8.1 China Specialty Injectable Generics Market Size (2015-2020)
8.2 Specialty Injectable Generics Key Players in China (2019-2020)
8.3 China Specialty Injectable Generics Market Size by Type (2015-2020)
8.4 China Specialty Injectable Generics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Specialty Injectable Generics Market Size (2015-2020)
9.2 Specialty Injectable Generics Key Players in Japan (2019-2020)
9.3 Japan Specialty Injectable Generics Market Size by Type (2015-2020)
9.4 Japan Specialty Injectable Generics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Specialty Injectable Generics Market Size (2015-2020)
10.2 Specialty Injectable Generics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Specialty Injectable Generics Market Size by Type (2015-2020)
10.4 Southeast Asia Specialty Injectable Generics Market Size by Application (2015-2020)

11 India
11.1 India Specialty Injectable Generics Market Size (2015-2020)
11.2 Specialty Injectable Generics Key Players in India (2019-2020)
11.3 India Specialty Injectable Generics Market Size by Type (2015-2020)
11.4 India Specialty Injectable Generics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Specialty Injectable Generics Market Size (2015-2020)
12.2 Specialty Injectable Generics Key Players in Central & South America (2019-2020)
12.3 Central & South America Specialty Injectable Generics Market Size by Type (2015-2020)
12.4 Central & South America Specialty Injectable Generics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Specialty Injectable Generics Introduction
13.1.4 Pfizer Revenue in Specialty Injectable Generics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Fresenius
13.2.1 Fresenius Company Details
13.2.2 Fresenius Business Overview
13.2.3 Fresenius Specialty Injectable Generics Introduction
13.2.4 Fresenius Revenue in Specialty Injectable Generics Business (2015-2020)
13.2.5 Fresenius Recent Development
13.3 Mylan N.V.
13.3.1 Mylan N.V. Company Details
13.3.2 Mylan N.V. Business Overview
13.3.3 Mylan N.V. Specialty Injectable Generics Introduction
13.3.4 Mylan N.V. Revenue in Specialty Injectable Generics Business (2015-2020)
13.3.5 Mylan N.V. Recent Development
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Details
13.4.2 Teva Pharmaceutical Business Overview
13.4.3 Teva Pharmaceutical Specialty Injectable Generics Introduction
13.4.4 Teva Pharmaceutical Revenue in Specialty Injectable Generics Business (2015-2020)
13.4.5 Teva Pharmaceutical Recent Development
13.5 Hikma Pharmaceuticals
13.5.1 Hikma Pharmaceuticals Company Details
13.5.2 Hikma Pharmaceuticals Business Overview
13.5.3 Hikma Pharmaceuticals Specialty Injectable Generics Introduction
13.5.4 Hikma Pharmaceuticals Revenue in Specialty Injectable Generics Business (2015-2020)
13.5.5 Hikma Pharmaceuticals Recent Development
13.6 Novartis AG
13.6.1 Novartis AG Company Details
13.6.2 Novartis AG Business Overview
13.6.3 Novartis AG Specialty Injectable Generics Introduction
13.6.4 Novartis AG Revenue in Specialty Injectable Generics Business (2015-2020)
13.6.5 Novartis AG Recent Development
13.7 Uman Pharma
13.7.1 Uman Pharma Company Details
13.7.2 Uman Pharma Business Overview
13.7.3 Uman Pharma Specialty Injectable Generics Introduction
13.7.4 Uman Pharma Revenue in Specialty Injectable Generics Business (2015-2020)
13.7.5 Uman Pharma Recent Development
13.8 Baxter
13.8.1 Baxter Company Details
13.8.2 Baxter Business Overview
13.8.3 Baxter Specialty Injectable Generics Introduction
13.8.4 Baxter Revenue in Specialty Injectable Generics Business (2015-2020)
13.8.5 Baxter Recent Development
13.9 Par Pharmaceutical
13.9.1 Par Pharmaceutical Company Details
13.9.2 Par Pharmaceutical Business Overview
13.9.3 Par Pharmaceutical Specialty Injectable Generics Introduction
13.9.4 Par Pharmaceutical Revenue in Specialty Injectable Generics Business (2015-2020)
13.9.5 Par Pharmaceutical Recent Development
13.10 Sagent Pharmaceuticals
13.10.1 Sagent Pharmaceuticals Company Details
13.10.2 Sagent Pharmaceuticals Business Overview
13.10.3 Sagent Pharmaceuticals Specialty Injectable Generics Introduction
13.10.4 Sagent Pharmaceuticals Revenue in Specialty Injectable Generics Business (2015-2020)
13.10.5 Sagent Pharmaceuticals Recent Development
13.11 Teligent
10.11.1 Teligent Company Details
10.11.2 Teligent Business Overview
10.11.3 Teligent Specialty Injectable Generics Introduction
10.11.4 Teligent Revenue in Specialty Injectable Generics Business (2015-2020)
10.11.5 Teligent Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Specialty Injectable Generics Key Market Segments
Table 2. Key Players Covered: Ranking by Specialty Injectable Generics Revenue
Table 3. Ranking of Global Top Specialty Injectable Generics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Specialty Injectable Generics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Type I
Table 6. Key Players of Type II
Table 7. Global Specialty Injectable Generics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Specialty Injectable Generics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Specialty Injectable Generics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Specialty Injectable Generics Market Share by Regions (2015-2020)
Table 11. Global Specialty Injectable Generics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Specialty Injectable Generics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Specialty Injectable Generics Market Growth Strategy
Table 17. Main Points Interviewed from Key Specialty Injectable Generics Players
Table 18. Global Specialty Injectable Generics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Specialty Injectable Generics Market Share by Players (2015-2020)
Table 20. Global Top Specialty Injectable Generics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Injectable Generics as of 2019)
Table 21. Global Specialty Injectable Generics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Specialty Injectable Generics Product Solution and Service
Table 24. Date of Enter into Specialty Injectable Generics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Specialty Injectable Generics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Specialty Injectable Generics Market Size Share by Type (2015-2020)
Table 28. Global Specialty Injectable Generics Revenue Market Share by Type (2021-2026)
Table 29. Global Specialty Injectable Generics Market Size Share by Application (2015-2020)
Table 30. Global Specialty Injectable Generics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Specialty Injectable Generics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Specialty Injectable Generics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Specialty Injectable Generics Market Share (2019-2020)
Table 34. North America Specialty Injectable Generics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Specialty Injectable Generics Market Share by Type (2015-2020)
Table 36. North America Specialty Injectable Generics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Specialty Injectable Generics Market Share by Application (2015-2020)
Table 38. Europe Key Players Specialty Injectable Generics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Specialty Injectable Generics Market Share (2019-2020)
Table 40. Europe Specialty Injectable Generics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Specialty Injectable Generics Market Share by Type (2015-2020)
Table 42. Europe Specialty Injectable Generics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Specialty Injectable Generics Market Share by Application (2015-2020)
Table 44. China Key Players Specialty Injectable Generics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Specialty Injectable Generics Market Share (2019-2020)
Table 46. China Specialty Injectable Generics Market Size by Type (2015-2020) (Million US$)
Table 47. China Specialty Injectable Generics Market Share by Type (2015-2020)
Table 48. China Specialty Injectable Generics Market Size by Application (2015-2020) (Million US$)
Table 49. China Specialty Injectable Generics Market Share by Application (2015-2020)
Table 50. Japan Key Players Specialty Injectable Generics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Specialty Injectable Generics Market Share (2019-2020)
Table 52. Japan Specialty Injectable Generics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Specialty Injectable Generics Market Share by Type (2015-2020)
Table 54. Japan Specialty Injectable Generics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Specialty Injectable Generics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Specialty Injectable Generics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Specialty Injectable Generics Market Share (2019-2020)
Table 58. Southeast Asia Specialty Injectable Generics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Specialty Injectable Generics Market Share by Type (2015-2020)
Table 60. Southeast Asia Specialty Injectable Generics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Specialty Injectable Generics Market Share by Application (2015-2020)
Table 62. India Key Players Specialty Injectable Generics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Specialty Injectable Generics Market Share (2019-2020)
Table 64. India Specialty Injectable Generics Market Size by Type (2015-2020) (Million US$)
Table 65. India Specialty Injectable Generics Market Share by Type (2015-2020)
Table 66. India Specialty Injectable Generics Market Size by Application (2015-2020) (Million US$)
Table 67. India Specialty Injectable Generics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Specialty Injectable Generics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Specialty Injectable Generics Market Share (2019-2020)
Table 70. Central & South America Specialty Injectable Generics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Specialty Injectable Generics Market Share by Type (2015-2020)
Table 72. Central & South America Specialty Injectable Generics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Specialty Injectable Generics Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Fresenius Company Details
Table 80. Fresenius Business Overview
Table 81. Fresenius Product
Table 82. Fresenius Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 83. Fresenius Recent Development
Table 84. Mylan N.V. Company Details
Table 85. Mylan N.V. Business Overview
Table 86. Mylan N.V. Product
Table 87. Mylan N.V. Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 88. Mylan N.V. Recent Development
Table 89. Teva Pharmaceutical Company Details
Table 90. Teva Pharmaceutical Business Overview
Table 91. Teva Pharmaceutical Product
Table 92. Teva Pharmaceutical Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 93. Teva Pharmaceutical Recent Development
Table 94. Hikma Pharmaceuticals Company Details
Table 95. Hikma Pharmaceuticals Business Overview
Table 96. Hikma Pharmaceuticals Product
Table 97. Hikma Pharmaceuticals Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 98. Hikma Pharmaceuticals Recent Development
Table 99. Novartis AG Company Details
Table 100. Novartis AG Business Overview
Table 101. Novartis AG Product
Table 102. Novartis AG Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 103. Novartis AG Recent Development
Table 104. Uman Pharma Company Details
Table 105. Uman Pharma Business Overview
Table 106. Uman Pharma Product
Table 107. Uman Pharma Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 108. Uman Pharma Recent Development
Table 109. Baxter Business Overview
Table 110. Baxter Product
Table 111. Baxter Company Details
Table 112. Baxter Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 113. Baxter Recent Development
Table 114. Par Pharmaceutical Company Details
Table 115. Par Pharmaceutical Business Overview
Table 116. Par Pharmaceutical Product
Table 117. Par Pharmaceutical Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 118. Par Pharmaceutical Recent Development
Table 119. Sagent Pharmaceuticals Company Details
Table 120. Sagent Pharmaceuticals Business Overview
Table 121. Sagent Pharmaceuticals Product
Table 122. Sagent Pharmaceuticals Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 123. Sagent Pharmaceuticals Recent Development
Table 124. Teligent Company Details
Table 125. Teligent Business Overview
Table 126. Teligent Product
Table 127. Teligent Revenue in Specialty Injectable Generics Business (2015-2020) (Million US$)
Table 128. Teligent Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Specialty Injectable Generics Market Share by Type: 2020 VS 2026
Figure 2. Type I Features
Figure 3. Type II Features
Figure 4. Global Specialty Injectable Generics Market Share by Application: 2020 VS 2026
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Case Studies
Figure 7. Central Nervous System Case Studies
Figure 8. Infectious Diseases Case Studies
Figure 9. Autoimmune Disorders Case Studies
Figure 10. Specialty Injectable Generics Report Years Considered
Figure 11. Global Specialty Injectable Generics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Specialty Injectable Generics Market Share by Regions: 2020 VS 2026
Figure 13. Global Specialty Injectable Generics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Specialty Injectable Generics Market Share by Players in 2019
Figure 16. Global Top Specialty Injectable Generics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Injectable Generics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Specialty Injectable Generics Revenue in 2019
Figure 18. North America Specialty Injectable Generics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Specialty Injectable Generics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Specialty Injectable Generics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Specialty Injectable Generics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Specialty Injectable Generics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Specialty Injectable Generics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Specialty Injectable Generics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed


【掲載企業】

Pfizer、Fresenius、Mylan N.V.、Teva Pharmaceutical、Hikma Pharmaceuticals、Novartis AG、Uman Pharma、Baxter、Par Pharmaceutical、Sagent Pharmaceuticals、Teligent

★調査レポート[世界の特殊注射用ジェネリック医薬品市場インサイト及び予測(~2026年)] (コード:QYR20NV04700)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の特殊注射用ジェネリック医薬品市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆